Transcriptomics

Dataset Information

0

Triple combination of BET plus pan-PI3K and NF-κB inhibitors exhibit synergistic activity in adult T cell leukemia/lymphoma

ABSTRACT: We exploited the use of I-BET762, copanlisib, and bardoxolone methyl inhibitors as triple combination to understand the interactions between these three pathways in Adult T cell leukemia/lymphoma.

ORGANISM(S): Homo sapiens

PROVIDER: GSE179307 | GEO | 2022/03/01

REPOSITORIES: GEO

Json Xml

Similar Datasets

Genomics Triple combination of BET plus pan-PI3K and NF-κB inhibitors exhibit synergistic activity in adult T cell leukemia/lymphoma
| PRJNA743091 | ENA
Unknown Concurrent PI3K and NF-κB activation drives B-cell lymphomagenesis.
| S-EPMC5093074 | biostudies-literature
Unknown The combination of BET and PARP inhibitors is synergistic in models of cholangiocarcinoma.
| S-EPMC7017643 | biostudies-literature
Unknown Synergistic antitumor activity of pan-PI3K inhibition and immune checkpoint blockade in bladder cancer.
| S-EPMC8562536 | biostudies-literature
Unknown PLCA8 suppresses breast cancer apoptosis by activating the PI3k/AKT/NF-κB pathway.
| S-EPMC6787500 | biostudies-literature
Transcriptomics IRAK1/4 and BET bromodomain inhibitions converge on NF-κB blockade and display synergistic antitumor activity in ABC-DLBCL with MYD88L265P mutation
2020-10-24 | GSE159915 | GEO
Unknown Combination treatment for myeloproliferative neoplasms using JAK and pan-class I PI3K inhibitors.
| S-EPMC4117552 | biostudies-literature
Unknown MARK2 enhances cisplatin resistance via PI3K/AKT/NF-κB signaling pathway in osteosarcoma cells.
| S-EPMC7270034 | biostudies-literature
Unknown Inhibition of NF-κB-Dependent Signaling Enhances Sensitivity and Overcomes Resistance to BET Inhibition in Uveal Melanoma.
| S-EPMC6643281 | biostudies-literature
Unknown Synergistic Tumor Cytolysis by NK Cells in Combination With a Pan-HDAC Inhibitor, Panobinostat.
| S-EPMC8438531 | biostudies-literature